Pseudomyxoma peritonei

Cancer Treatment Reviews

Volumn 33, Issue 2, 2007, Pages 138-145

  Smeenk, R M ^a   Verwaal, V J ^a   Zoetmulder, F A N ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Diagnosis; Outcome; Pathogenesis; Pseudomyxoma peritonei; Treatment

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL; MITOMYCIN C; OXALIPLATIN;

ABDOMINAL SURGERY; ACUTE APPENDICITIS; APPENDECTOMY; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOCHEMISTRY; IMMUNOSCINTIGRAPHY; INTESTINE OBSTRUCTION; LAPAROSCOPY; LAPAROTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTOPLASTY; OVARIECTOMY; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PATIENT CARE; PERITONEUM PSEUDOMYXOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SYMPTOM; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HUMANS; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI;

EID: 33847246892     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2006.11.001     Document Type: Review

References (73)

1. Mann Jr. W.J., Wagner J., Chumas J., et al. The management of pseudomyxoma peritonei. Cancer 66 (1990) 1636-1640
2. Mukherjee A., Parvaiz A., Cecil T.D., et al. Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 25 (2004) 411-414
3. Smith J.W., Kemeny N., Caldwell C., et al. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 70 (1992) 396-401
4. Sherer D.M., Abulafia O., and Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 51 (2001) 73-80
5. Werth R. Klinische und anatomische untersuchungen zur lehre von den bauchgeschwuelsten und der laparotomie. Arch Gynaecol Obstet 24 (1884) 100-118
6. Frankel E. Uber das sogenannte pseudomyxoma peritonei. Med Wochenschr (1901) 965-970
7. Sugarbaker P.H. Pseudomyxoma peritonei. Cancer Treat Res 81 (1996) 105-119
8. Young R.H. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Semin Diagn Pathol 21 (2004) 134-150
9. Hinson F.L., and Ambrose N.S. Pseudomyxoma peritonei. Br J Surg 85 (1998) 1332-1339
10. Sugarbaker P.H. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 219 (1994) 109-111
11. Prayson R.A., Hart W.R., and Petras R.E. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 18 (1994) 591-603
12. Young R.H., Gilks C.B., and Scully R.E. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 15 (1991) 415-429
13. Lamps L.W., Gray Jr. G.F., Dilday B.R., et al. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei. Mod Pathol 13 (2000) 495-501
14. Guerrieri C., Franlund B., Fristedt S., et al. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol 28 (1997) 1039-1045
15. Szych C., Staebler A., Connolly D.C., et al. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol 154 (1999) 1849-1855
16. Ronnett B.M., Shmookler B.M., Diener-West M., et al. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16 (1997) 1-9
17. Ronnett B.M., Kurman R.J., Zahn C.M., et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 26 (1995) 509-524
18. Ronnett B.M., Shmookler B.M., Sugarbaker P.H., et al. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 2 (1997) 197-226
19. Seidman J.D., Elsayed A.M., Sobin L.H., et al. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol 17 (1993) 22-34
20. Chuaqui R.F., Zhuang Z., Emmert-Buck M.R., et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 27 (1996) 165-171
21. Jacquemin G., and Laloux P. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases. Acta Chir Belg 105 (2005) 127-133
22. de Bree E., Witkamp A., Van De Vijver M., et al. Unusual origins of Pseudomyxoma peritonei. J Surg Oncol 75 (2000) 270-274
23. Smeenk R.M., Bex A., Verwaal V.J., et al. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. J Surg Oncol 93 (2006) 20-23
24. Ronnett B.M., Zahn C.M., Kurman R.J., et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to pseudomyxoma peritonei. Am J Surg Pathol 19 (1995) 1390-1408
25. Bradley R.F., Stewart J.H., Russell G.B., et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 30 (2006) 551-559
26. Ronnett B.M., Yan H., Kurman R.J., et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92 (2001) 85-91
27. Smeenk RM, Verwaal VJ, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei treated by cytoreductive surgery in combination with intraoperative hyperthermic intraperitoneal chemotherapy. Ann Surg, in press.
28. Baker W.C., Goldman L.B., and deVere White R.W. Pseudomyxoma peritonei presenting as a scrotal mass. J Urol 139 (1988) 821-822
29. Young R.H., Rosenberg A.E., and Clement P.B. Mucin deposits within inguinal hernia sacs: a presenting finding of low-grade mucinous cystic tumors of the appendix. A report of two cases and a review of the literature. Mod Pathol 10 (1997) 1228-1232
30. Kalu E., and Croucher C. Appendiceal mucocele: a rare differential diagnosis of a cystic right adnexal mass. Arch Gynecol Obstet 271 (2005) 86-88
31. Khan S., Patel A.G., and Jurkovic D. Incidental ultrasound diagnosis of pseudomyxoma peritonei in an asymptomatic woman. Ultrasound Obstet Gynecol 19 (2002) 410-412
32. Darnis E., Ronceray J., Grosieux P., et al. Pseudomyxoma peritonei in females. 13 personal cases. Practical deductions from a review of 420 cases in the literature. J Gynecol Obstet Biol Reprod (Paris) 16 (1987) 343-353
33. Solkar M.H., Akhtar N.M., Khan Z., et al. Pseudomyxoma extraperitonei occurring 35 years after appendicectomy: a case report and review of literature. World J Surg Oncol 2 (2004) 19
34. Bechtold R.E., Chen M.Y., Loggie B.W., et al. CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 26 (2001) 406-410
35. Hanbidge A.E., Lynch D., and Wilson S.R. US of the peritoneum. Radiographics 23 (2003) 663-684
36. Tsai C.J. Ultrasound features of disseminated adenomucinosis (pseudomyxoma). Br J Radiol 71 (1998) 564-566
37. Kairemo K.J., Jekunen A.P., Bondestam S., et al. Detection of pseudomyxoma peritonei by radioimmunohistochemistry and radioimmunoscintigraphy. Cancer Biother Radiopharm 11 (1996) 325-334
38. Buy J.N., Malbec L., Ghossain M.A., et al. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 9 (1989) 115-118
39. Sulkin T.V., O'Neill H., Amin A.I., et al. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 57 (2002) 608-613
40. Carmignani C.P., Hampton R., Sugarbaker C.E., et al. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 87 (2004) 162-166
41. Friedland J.S., Allardice J.T., and Wyatt A.P. Pseudomyxoma peritonei. J R Soc Med 79 (1986) 480-482
42. Haid M., Bowie L., Kim D., et al. Peritoneal washing therapy for pseudomyxoma peritonei. South Med J 74 (1981) 913-915
43. Green N., Gancedo H., Smith R., et al. Pseudomyxoma peritonei - nonoperative management and biochemical findings. A case report. Cancer 36 (1975) 1834-1837
44. Jones III C.M., and Homesley H.D. Successful treatment of pseudomyxoma peritonei of ovarian origin with cis-platinum, doxorubicin, and cyclophosphamide. Gynecol Oncol 22 (1985) 257-259
45. Piver M.S., Lele S.B., and Patsner B. Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage. Obstet Gynecol 64 (1984) 95S-96S
46. Carter J., Moradi M.M., Elg S., et al. Pseudomyxoma peritonei - experience from a tertiary referral centre. Aust N Z J Obstet Gynaecol 31 (1991) 177-178
47. Wertheim I., Fleischhacker D., McLachlin C.M., et al. Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol 84 (1994) 17-21
48. Galani E., Marx G.M., Steer C.B., et al. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer 13 (2003) 413-418
49. Gough D.B., Donohue J.H., Schutt A.J., et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 219 (1994) 112-119
50. Miner T.J., Shia J., Jaques D.P., et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241 (2005) 300-308
51. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol 7 (2006) 69-76
52. Kusamura S., Younan R., Baratti D., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 106 (2006) 1144-1153
53. Raspagliesi F., Kusamura S., Campos Torres J.C., et al. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan. Eur J Surg Oncol (2006)
54. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
55. Brigand C., Monneuse O., Mohamed F., et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 13 (2006) 405-412
56. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
57. Sugarbaker P.H., Ronnett B.M., Archer A., et al. Pseudomyxoma peritonei syndrome. Adv Surg 30 (1996) 233-280
58. Sugarbaker P.H. Peritonectomy procedures. Surg Oncol Clin N Am 12 (2003) 703-727 xiii
59. Sugarbaker P.H. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27 (2001) 239-243
60. Butterworth S.A., Panton O.N., Klaassen D.J., et al. Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei. Am J Surg 183 (2002) 529-532
61. Elias D., Laurent S., Antoun S., et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol 27 (2003) 407-412
62. Guner Z., Schmidt U., Dahlke M.H., et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 20 (2005) 155-160
63. Loungnarath R., Causeret S., Bossard N., et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 48 (2005) 1372-1379
64. Smeenk R.M., Verwaal V.J., and Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur J Surg Oncol (2005)
65. Scuderi S., Costamagna D., Vaira M., et al. Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy. Tumori 89 (2003) 43-45
66. Deraco M., Baratti D., Inglese M.G., et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11 (2004) 393-398
67. Witkamp A.J., de Bree E., Van Goethem R., et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27 (2001) 365-374
68. Moran B.J. Establishment of a peritoneal malignancy treatment centre in the United Kingdom. Eur J Surg Oncol 32 (2006) 614-618
69. Sindelar W.F., DeLaney T.F., Tochner Z., et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg 126 (1991) 318-324
70. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Progressive pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol, 2006 [Epub ahead of print].
71. Zoetmulder F.A., and Sugarbaker P.H. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 32A (1996) 1727-1733
72. van Ruth S., Hart A.A., Bonfrer J.M., et al. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 9 (2002) 961-967
73. Alexander-Sefre F., Chandrakumaran K., Banerjee S., et al. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 7 (2005) 382-386